Sonova
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, Sonova sits in the top decile of US sponsors by registered trial count (#553 of 15,742 sponsors by registered trial count).
Sonova: 29 sponsored US clinical trials, 1 recruiting.
Sonova sponsors 29 registered US clinical trials on ClinicalTrials.gov, 1 of them currently recruiting, and 24 completed. The most-studied condition in this pipeline is Hearing Loss, with 3 trials.
Top-decile sponsor footprint
Sonova ranks in the top decile of sponsors by registered trial count (#553 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
24 of 26 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (92.3%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
29 total, page 1 of 1
Speech Understanding and Listening Effort Benefits of Hearing Instruments
NCT07116135
Investigating the DNN Noise Reduction Feature in Phonak Hearing Aids Using Ecological Momentary Assessment
NCT07526428
Remote Microphone Performance Comparison in Adults With Hearing Loss
NCT07501312
A Comparison of Hearing Aid Noise Programs on Speech Intelligibility
NCT06957730
Evaluation of Extended Wear Hearing Aid for Mild Hearing Loss
NCT06746038
Evaluation of Investigational Hearing Instrument Features
NCT06710236
Venting Effects on Speech Performance
NCT06712693
A Pediatric Comparison of Remote Microphone Technologies
NCT06564701
Phonak Behind-The-Ear Quality Evaluation
NCT05956808
Speech Locator_Benefits in Pediatric Popluations
NCT06533774
Noise Reduction Preferences in Teenagers and Pre-teens
NCT05372094
A Comparison of Hearing Aid Fitting Methods
NCT05376215
Lyric Self-replacement Clinical Investigation
NCT05349981
Real World Perspectives on Advancements in Hearing Aid Technology
NCT05468918
Evaluation of the Clinical Benefit of the Hearing Aids Tinnitus Feature.
NCT05292534
Effect of Hearing Aid Labeling on Speech Understanding Measures
NCT05274178
Evaluation of New Fitting Characteristics for Extended Wear Hearing Aid Technology
NCT05274165
Optimizing Soft Speech Recognition in Children With Hearing Loss
NCT05299892
Evaluation of Hearing Aid Benefit
NCT05198713
Benefit of Assistive Listening Device for Lateralization
NCT05072457
Benefits of Assistive Listening Device for Speech Intelligibility
NCT05072470
Sound Quality Comparisons With Different Hearing Aid Couplings and Venting Systems
NCT05180630
Hearing Aid Signal Processing Comparative Study
NCT04839289
Hearing Aid Quality and Reliability Study
NCT04995666
Measuring Comfort and Clarity With Low Gain Feature in Pediatric Hearing Aid Users
NCT05150964
Clinical Performance Evaluation of 3D Ear Canal Scanning Technology
NCT05000047
Evaluating Benefits of Hearing Aid Microphone Directionality Technologies
NCT04953390
Evaluation of Extended Wear Technology
NCT04882800
In Field Performance of a Hearing Aid Transducer
NCT04787055
Therapeutic Areas
What is open in the Sonova pipeline
1 recruiting of 29 indexed (3% open); 24 completed (83%).
Phase labels are sparse on this sponsor index, so phase mix is not charted here.
Top condition: Hearing Loss (3 trials), 2 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Sonova: open-pipeline peers nationwide
Peers matched on 29 registered trials and 3% open enrollment, not the therapeutic-area sidebar.
Sonova sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 29 trials (± recruiting share)
- BeOne Medicines · 29 trials · 79% recruiting
- BioCryst Pharmaceuticals · 29 trials · 7% recruiting
- California Pacific Medical Center Research Institute · 29 trials · 10% recruiting
- Center for International Blood and Marrow Transplant Research · 29 trials · 24% recruiting
Sponsors near 3% open enrollment (± trial volume)
- Medtronic MiniMed · 3% recruiting · 29 trials
- Sandoz · 3% recruiting · 29 trials
- USDA Beltsville Human Nutrition Research Center · 3% recruiting · 29 trials
- SCRI Development Innovations · 3% recruiting · 146 trials
Related
What to do with this Sonova page
29 registered trials is a research-attention snapshot, not an endorsement of Sonova or any single study.
- 1 of Sonova's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Hearing Loss is the condition Sonova studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Hearing Loss trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Sonova pipeline card: 29 registered trials from official public datasets.Report a data error.